BIOTRONIK Launches its Pulsar-18 T3 Self-Expanding Stent System in the U.S.
BIOTRONIK announced that it received U.S. Food and Drug Administration (FDA) approval of its innovative Pulsar®-18 T3 peripheral self-expanding stent system for an improved implantation procedure for endovascular treatments. The company also announced the full U.S. commercial launch of the device, which will begin in early August.